Suven Life Sciences [SUVEN] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Suven Life Sciences

NSE
Loading...

Divi's Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Suven Life Sciences wins in 7 metrics, Divi's Laboratories wins in 11 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSuven Life SciencesDivi's LaboratoriesBetter
P/E Ratio (TTM)-28.0165.37Suven Life Sciences
Price-to-Book Ratio40.4910.13Divi's Laboratories
Debt-to-Equity Ratio0.000.03Suven Life Sciences
PEG Ratio-0.342.47Suven Life Sciences
EV/EBITDA-23.3248.31Suven Life Sciences
Profit Margin (TTM)84.44%23.89%Suven Life Sciences
Operating Margin (TTM)-2,791.92%25.60%Divi's Laboratories
EBITDA Margin (TTM)N/A25.60%N/A
Return on Equity-146.15%14.64%Divi's Laboratories
Return on Assets (TTM)-118.91%12.94%Divi's Laboratories
Free Cash Flow (TTM)$-1.91B$2.15BDivi's Laboratories
Dividend YieldN/A0.91%N/A
1-Year Return46.77%8.12%Suven Life Sciences
Price-to-Sales Ratio (TTM)641.2615.71Divi's Laboratories
Enterprise Value$43.40B$1,480.60BDivi's Laboratories
EV/Revenue Ratio577.3815.34Divi's Laboratories
Gross Profit Margin (TTM)100.00%60.33%Suven Life Sciences
Revenue per Share (TTM)$0$363Divi's Laboratories
Earnings per Share (Diluted)$-8.15$87.36Divi's Laboratories
Beta (Stock Volatility)0.860.18Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Suven Life Sciences vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Suven Life Sciences
Divi's Laboratories
Suven Life Sciences Stock Overview | Divi's Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Suven Life Sciences0.76%-0.17%-3.10%-15.83%58.82%63.15%
Divi's Laboratories2.73%3.10%-4.83%-14.69%1.79%-3.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Suven Life Sciences46.77%186.97%307.88%-25.87%594.28%3,728.07%
Divi's Laboratories8.12%57.02%83.89%435.51%1,516.65%7,132.15%

News Based Sentiment: Suven Life Sciences vs Divi's Laboratories

Suven Life Sciences

News based Sentiment: POSITIVE

The month of October 2025 saw Suven Life Sciences benefit from both company-specific gains and a broader pharmaceutical rally, indicating a positive trend for the company. The Pfizer agreement acted as a catalyst for this positive movement, suggesting a favorable market environment.

View Suven Life Sciences News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

September presented a mixed bag for Divi's Laboratories, with stellar FY25 results overshadowed by a weaker Q1 FY26 performance and fluctuating analyst opinions. The Nifty 50 exclusion adds another layer of complexity, creating a dynamic investment scenario that requires careful monitoring.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Suven Life Sciences vs Divi's Laboratories

MetricSUVENDIVISLAB
Market Information
Market Cap i₹48.20B₹1.61T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i185,019437,716
90 Day Avg. Volume i147,095381,180
Last Close₹208.63₹5,866.00
52 Week Range₹102.50 - ₹299.99₹4,955.00 - ₹7,071.50
% from 52W High-30.45%-17.05%
All-Time High₹338.50 (Apr 13, 2015)₹7,071.50 (Jul 08, 2025)
% from All-Time High-38.37%-17.05%
Growth Metrics
Quarterly Revenue Growth0.86%0.14%
Quarterly Earnings Growth0.86%0.27%
Financial Health
Profit Margin (TTM) i0.84%0.24%
Operating Margin (TTM) i-27.92%0.26%
Return on Equity (TTM) i-1.46%0.15%
Debt to Equity (MRQ) i0.000.03
Cash & Liquidity
Book Value per Share (MRQ)₹5.04₹563.87
Cash per Share (MRQ)₹2.75₹132.86
Operating Cash Flow (TTM) i₹-1,590,282,000₹19.67B
Levered Free Cash Flow (TTM) i₹-1,607,450,000₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend i₹0.00₹60.00

Valuation & Enterprise Metrics Analysis: Suven Life Sciences vs Divi's Laboratories

MetricSUVENDIVISLAB
Price Ratios
P/E Ratio (TTM) i-28.0165.37
Forward P/E i10.55101.43
PEG Ratio i-0.342.47
Price to Sales (TTM) i641.2615.71
Price to Book (MRQ) i40.4910.13
Market Capitalization
Market Capitalization i₹48.20B₹1.61T
Enterprise Value i₹43.40B₹1.48T
Enterprise Value Metrics
Enterprise to Revenue i577.3815.34
Enterprise to EBITDA i-23.3248.31
Risk & Other Metrics
Beta i0.860.18
Book Value per Share (MRQ) i₹5.04₹563.87

Financial Statements Comparison: Suven Life Sciences vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SUVENDIVISLAB
Revenue/Sales i₹18.67M₹24.10B
Cost of Goods Sold i₹0₹9.56B
Gross Profit i₹18.67M₹14.54B
Research & Development i₹414.88MN/A
Operating Income (EBIT) i₹-521.17M₹6.17B
EBITDA i₹-501.49M₹8.48B
Pre-Tax Income i₹-515.17M₹7.33B
Income Tax i₹0₹1.88B
Net Income (Profit) i₹-515.17M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SUVENDIVISLAB
Cash & Equivalents i₹150.26M₹4.15B
Total Current Assets i₹754.72M₹100.81B
Total Current Liabilities i₹234.86M₹14.52B
Long-Term Debt iN/A₹20.00M
Total Shareholders Equity i₹1.10B₹149.69B
Retained Earnings i₹-6.01B₹134.00B
Property, Plant & Equipment i₹756.69M₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SUVENDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSUVENDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i185,019437,716
Average Daily Volume (90 Day) i147,095381,180
Shares Outstanding i218.07M265.47M
Float Shares i67.61M120.77M
% Held by Insiders i0.69%0.52%
% Held by Institutions i0.02%0.29%

Dividend Analysis & Yield Comparison: Suven Life Sciences vs Divi's Laboratories

MetricSUVENDIVISLAB
Last 12-Month Dividend i₹0.00₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend i₹0.00₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends i₹0.00₹150.00
Ex-Dividend DateN/AJul 25, 2025